A Phase II, Single-Stage, Single Arm Investigation of Oral Valganciclovir Therapy in Infants with Asymptomatic Congenital Cytomegalovirus Infection

Grant

Date/time Interval

  • July 1, 2016 - April 3, 2022

    • Awarded By

    Total Award Amount

  • 3716696.00

    • Direct Costs

  • 3145076.00

    • Sponsor Award Id

  • HHSN272201600017C

    • Contributor

  • David Kimberlin M.D.   Principal Investigator  
  • Edward Acosta Pharm.D.   Investigator  
  • Inmaculada Aban   Investigator  
  • Karen Fowler   Investigator  
  • Richard Whitley M.D.   Investigator  
  • Scott James   Investigator  
  • Suresh Boppana M.D.   Investigator